This inventor holds 1 USPTO granted patent. Top assignee: Sun Pharmaceutical Industries (Australia) Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yi Li and Plant Alkaloid Innovation.
Introduction
Yi Li is an inventor associated with research into the regulation of benzylisoquinoline alkaloid synthesis in the opium poppy, *Papaver somniferum*. The supplied information identifies one patent associated with his work.
Latest Patents
The listed patent is “Papaver somniferum Plants with a Modified Transcription Factor Gene in the Regulation of Benzylisoquinoline Alkaloids Synthesis.” It concerns modifying a transcription factor gene to influence the synthesis of benzylisoquinoline alkaloids in *Papaver somniferum*. The supplied data lists 1 patent for Yi Li.
Career Highlights
Yi Li is associated with Sun Pharmaceutical Industries (Australia) Pty Ltd. The available information does not specify his role, career history, or the location of his work.
Collaborations
Yi Li’s listed coworker is Ian Graham, who is also associated with the patent information provided.
Conclusion
Yi Li’s listed patent reflects work on genetic regulation of alkaloid synthesis in *Papaver somniferum*, with Sun Pharmaceutical Industries (Australia) Pty Ltd and coworker Ian Graham noted in the supplied information.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile